Form 4 for RMD ResMed|
Accepted 2021-09-13 00:00:00 ET · period of report 2021-09-10 · accession 0001127602-21-025210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-13 | 2021-09-10 | RMD | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 92.3K | +3% | +$144.4K |
| D | 2021-09-13 | 2021-09-10 | RMD | Sandercock Brett | CFO | S - Sale+OE | $297.33 | -5,000 | 87.3K | -5% | -$1.49M |
| D | 2021-09-13 | 2021-09-10 | RMD | Sandercock Brett | CFO | M - OptEx | $0.00 | -2,500 | 27.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-09-10 | M | A | 2,500 | $57.76 | 92,286 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2021-09-10 | S | D | 5,000 | $297.33 | 87,286 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2021-09-10 | M | D | 2,500 | $0.00 | 27,500 | D | $57.76 · 2017-11-11 to 2023-11-16 | 2,500 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |